Faculty profile

Matthieu Pelletier-Galarneau

ResearcherDiagnostic Radiology and Nuclear MedicineUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Matthieu Pelletier-Galarneau

Researcher

Diagnostic Radiology and Nuclear Medicine

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
43 publications in the last five years, latest in 2026.
Senior (last) author on 16 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Infective Endocarditis Positron Emission Tomography

Latest papers

A sex-specific perspective on coronary microvascular dysfunction in HFpEF: from vascular to myocardial disease.
Heart failure reviews · 2026
Improved assessment of coronary artery disease in obese patients with flurpiridaz-18F positron emission tomography myocardial perfusion imaging: A prespecified subgroup analysis of the AURORA phase 3 study.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2026
Resolution of microvascular ischemia following alcohol septal ablation in hypertrophic cardiomyopathy: Evidence from rubidium-82 positron emission tomography.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2026 · senior author

All 64 publications

Latest funding

Investigations into the pathophysiology of heat-related cardiovascular risk
CIHR · 2022 · Co-investigator
$432,226
Multiparametric Cardiac Positron Emission Tomography for Cardiac Allograft Vasculopathy Surveillance After Heart Transplantation: MARINER Trial
CIHR · 2022 · Co-investigator
$952,425
Impact of 18F-FDG-PET/CT on Management of Patients with Suspected Native Valve Infective Endocarditis
CIHR · 2021 · Nominated PI
$210,000

All 3 grants and awards

64 publications.

A sex-specific perspective on coronary microvascular dysfunction in HFpEF: from vascular to myocardial disease.

Roy AS, Jolicoeur EM, Bérubé L, Forcillo J, Pacheco C, Potter BJ, Pelletier-Galarneau M, Bouabdallaoui N

Heart failure reviews2026

DOI: 10.1007/s10741-026-10661-z PMID: 42493631

Improved assessment of coronary artery disease in obese patients with flurpiridaz-18F positron emission tomography myocardial perfusion imaging: A prespecified subgroup analysis of the AURORA phase 3 study.

Patel KK, Maddahi J, Agostini D, Bax JJ, Beanlands RSB, Berman D, Dorbala S, Heller GV, Knuuti JM, Pelletier-Galarneau M, Tamaki N, Thompson D, Somer EJ, Udelson JE, Bateman TM

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2026

DOI: 10.1016/j.nuclcard.2026.102741 PMID: 42128226

Resolution of microvascular ischemia following alcohol septal ablation in hypertrophic cardiomyopathy: Evidence from rubidium-82 positron emission tomography.

Melhem HB, Lanctôt-Bédard J, Boulet J, Tadros R, Pelletier-Galarneau M

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2026Senior author

DOI: 10.1016/j.nuclcard.2026.102682 PMID: 41831813

Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER).

Akincioglu C, Aleksova N, Fine N, Juneau D, Ruddy TD, Small G, Pelletier-Galarneau M, Wells G, Miller RJH

The Canadian journal of cardiology2025

DOI: 10.1016/j.cjca.2025.08.357 PMID: 40930492

Artificial intelligence-enabled parametric mapping of myocardial blood flow with 82Rb positron emission tomography compared to 18F-flurpiridaz perfusion imaging: A paired pilot study of image quality.

Moulton E, Gagliano L, Kaviani S, Klein R, deKemp R, Pelletier-Galarneau M

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2025Senior author

DOI: 10.1016/j.nuclcard.2025.102531 PMID: 41093107

SNMMI/EANM/ASNC/ACNM procedure standard/practice guideline for 18F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation.

Packard RRS, Maddahi J, Pelletier-Galarneau M, Al-Mallah MH, Coelho M, Dorbala S, Galt J, Hyun M, Menon N, Miller EJ, Shetty M, Saraste A

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2025

DOI: 10.1016/j.nuclcard.2025.102473 PMID: 41086188

SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for 18F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow Quantitation.

Packard RRS, Maddahi J, Pelletier-Galarneau M, Al-Mallah MH, Coelho M, Dorbala S, Galt J, Hyun M, Menon N, Miller EJ, Shetty M, Saraste A

Journal of nuclear medicine : official publication, Society of Nuclear Medicine2025

DOI: 10.2967/jnumed.125.270873 PMID: 40967753

Role of rubidium-82 positron emission tomography in a multimodality approach to diagnosing coronary microvascular dysfunction in apical hypertrophic cardiomyopathy.

Nazif K, Abuzaid AS, Horgan S, Patel KK, Pelletier-Galarneau M, Naneishvili T, Heller G, Arumugam P

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2025

DOI: 10.1016/j.nuclcard.2025.102197 PMID: 40147523

Sharpening the Target: Fibroblast Activation Protein Inhibitor Imaging in Dilated Cardiomyopathy.

Pelletier-Galarneau M, Regis C

JACC. Cardiovascular imaging2025First author

DOI: 10.1016/j.jcmg.2025.06.016 PMID: 40908070

Fulminant Myocarditis After mRNA COVID-19 Vaccine Evolving to Giant Cell Myocarditis.

Ouimet-Grennan E, Parent MC, Tremblay-Gravel M, Pelletier-Galarneau M, Boulet J

JACC. Case reports2025

DOI: 10.1016/j.jaccas.2025.105078 PMID: 40883063

Something wrong or missing on this profile? Suggest a correction

Matthieu Pelletier-Galarneau

Research

Latest papers

Latest funding

A sex-specific perspective on coronary microvascular dysfunction in HFpEF: from vascular to myocardial disease.

Improved assessment of coronary artery disease in obese patients with flurpiridaz-18F positron emission tomography myocardial perfusion imaging: A prespecified subgroup analysis of the AURORA phase 3 study.

Resolution of microvascular ischemia following alcohol septal ablation in hypertrophic cardiomyopathy: Evidence from rubidium-82 positron emission tomography.

Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER).

Artificial intelligence-enabled parametric mapping of myocardial blood flow with 82Rb positron emission tomography compared to 18F-flurpiridaz perfusion imaging: A paired pilot study of image quality.

SNMMI/EANM/ASNC/ACNM procedure standard/practice guideline for 18F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation.

SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for 18F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow Quantitation.

Role of rubidium-82 positron emission tomography in a multimodality approach to diagnosing coronary microvascular dysfunction in apical hypertrophic cardiomyopathy.

Sharpening the Target: Fibroblast Activation Protein Inhibitor Imaging in Dilated Cardiomyopathy.

Fulminant Myocarditis After mRNA COVID-19 Vaccine Evolving to Giant Cell Myocarditis.

Investigations into the pathophysiology of heat-related cardiovascular risk

Multiparametric Cardiac Positron Emission Tomography for Cardiac Allograft Vasculopathy Surveillance After Heart Transplantation: MARINER Trial

Impact of 18F-FDG-PET/CT on Management of Patients with Suspected Native Valve Infective Endocarditis

Frequent collaborators

Gad Abikhzer

Maxime Tremblay-Gravel

Guillaume Marquis-Gravel

Daniel Gagnon

Ran Klein

Julia Cadrin-Tourigny

Robert deKemp

Louis Bherer

Rob Beanlands

David Birnie

Pablo Nery

Anil Nigam

Rafik Tadros

Jean-Claude Moubarac

David Kaiser

Paul Khairy